Open Access
Subscription Access
Policy as a Driver of Economic Growth:Historical Evidence from the Indian Pharmaceutical Industry
Sound implementation of a well-crafted policy decision allows for technological innovation and sectoral economic proliferation. The rise of the Indian pharmaceutical sector is a classic example in this context. This article aims to trace the evolution of the Indian pharmaceutical industry, highlighting the robust policy decisions favouring the proliferation of the pharmaceutical industry. The national linkages in the form of institutional capacity building and technological improvements have also been focused upon.
Keywords
Health Policy, Indian Pharmaceutical Industry History, Open Source, Science Policy History, Science and Technology Policy.
User
Font Size
Information
- PwC, P.W.C., India Pharma Inc. Changing Landscape of the Indian Pharma Industry, 2013.
- IBEF, I.B.E.F., Indian Pharmaceuticals Industry Analysis, 2017.
- Curzon, G. N., The Place of India in the Empire: Being an Address Delivered Before the Philosophical Institute of Edinburgh (ed. Murray, J.), University of California Libraries, London, 1909, p. 60.
- Subbarayappa, B. V., Science in India: A Historical Perspective, Rupa Publications, 2014, p. 624.
- Sheriff, M., Materia Medica of Madras, Volume I, Government Press: Madras (India), 1891, p. 81.
- Macaulay, T. B. M. and Young, G. M., Speeches / by Lord Macaulay, with his Minute on Indian education. Selected with an intro. and notes by G. M. Young London, London, 1835.
- Harrison, M., Public Health and Medicine in British India: An Assessment of the British Contribution, in Liverpool Medical History Society Meeting, Cambridge University Press, Liverpool, 1998, pp. 32–48.
- Mushtaq, M. U., Public Health in British India: A brief account of the history of medical services and disease prevention in Colonial India. Indian J. Community Med., 2009, 34(1), 6–14.
- M.o.H.F.W, M.o.H.a.F.W., The Drugs and Cosmetics Act, 1940, D.o. Health, Editor. Government of India, New Delhi, 1940, pp. 1-30.
- Khader, A. F., The Law of Patents – With a Special Focus on Pharmaceuticals in India, LexisNexis Butterworths Wadhwa Nagpur, New Delhi, 2009, p. 771.
- RBI, R.B.o.I., Foreign Collaboration in Indian Industry: Second Survey Report, R.B.o. India, Editor. Bombay, 1985.
- Ghosh, S., Bhagwati-Sen Debate, 2002; http://home.fau.edu/sghosh/web/images/Indiatalk.pdf.
- https://spicyip.com/wp-content/uploads/2013/10/ayyangar_committee_report.pdf
- GOI, G.o.I., Pharmaceutical: Manufacture, Not processing, M.o.C.a. Industry, Editor. 1954: New Delhi.
- https://spicyip.com/wp-content/uploads/2013/10/ayyangar_committee_report.pdf
- http:/pharmaceuticals.gov.in/sites/default/files/Hathi_Committee_report_1975_0.pdf
- http://nppaindia.nic.in
- http://dipp.nic.in/English/Policies/Industrial_policy_statement.pdf
- Sahu, S. K., Globalization and the Indian Pharmaceutical Industry, 2014.
- https://www.rbi.org.in/Scripts/BS_FemaNotifications.aspx?Id=179
- Chaudhuri, S., The WTO and India’s Pharmaceuticals Industry: Patent protection, TRIPS, and Developing Countries, Oxford University Press, New Delhi, 2005,
- Ray, A. S. and Bhaduri, S., Competing Through Technological Capability, CSSP Electronic Working Paper Series, 2012(3).
- Chaturvedi, K. and Chataway, J., Policy and technology co-evolution in the Indian pharmaceutical industry. In Development Policy and Practice Working Paper (ed. Umversity, T. O.), United Kingdom, 2005.
- Taneja, B. et al., An Indian effort towards affordable drugs: generic to designer drugs. Biotechnol. J., 2009, 4(3), 348–360.
- Gokarn, S., Sen, A. and Vaidya, R. R. (eds), The Strcture of Indian Industry, Oxford University Press, 2004.
- Watal, J., Intellectual Property Rights in the WTO and Developing Countries, Springer, 2001.
- Mueller, J. M., The tiger awakens: the tumultuous transformation of India’s patent system and the rise of Indian pharmaceutical innovation. Univ. Pittbg. Law Rev., 2006. 68, 491.
- Abraham, R. M. K. and Wankhar, D. L., Drug Price Control Orders (DPCO), 2015; http://arthapedia.in/index.php?title=Drug_Price_Control_Orders_(DPCO).
- http://pharmaceuticals.gov.in/project/national-pharmaceutical-pricing-policy-2012
- Chaudhuri, S., Intellectual property rights and innovation: MNCs in pharmaceutical industry in India after TRIPS. ISID, Institute for Studies in Industrial Development, 2015.
- Chaudhuri, S., Intellectual Property Rights and Innovation. MNCs in Pharmaceutical Industry in India after TRIPS, in Working Papers, ISID, Institute for Studies in Industrial Development, New Delhi, 2014.
- Unnikrishnan, C. H., Domestic Drug Sales Cross Rs 87,000 crore Despite Pricing Control, 2015; http://www.livemint.com/Politics/HyWhMhav6opaXRdVxd9gnK/Domestic-drug-sales-cross-Rs87000-crore-despite-pricing-con.html
- Joseph, R. K., The R&D Scenario in the Indian Pharmaceutical Industry, 2012.
- PNB, P.N.B. 2017.
- http://dipp.nic.in/English/Schemes/Intellectual_Property_Rights/National_IPR_Policy_08.08.2016.pdf
Abstract Views: 465
PDF Views: 132